Phase 1, Open Label, Randomized, 3-sequence, 3-period, Single Dose Study Assessing the Effect of Food on the Bioavailability of Venglustat Tablet and Comparing the Relative Bioavailability of Venglustat Tablet Chewed Versus Tablet Swallowed Whole
Latest Information Update: 21 May 2024
At a glance
- Drugs Venglustat (Primary)
- Indications Fabry's disease; Gaucher's disease; Gaucher's disease type III; GM2 gangliosidoses; Polycystic kidney disease
- Focus Pharmacokinetics
- Sponsors Sanofi
- 21 May 2024 New trial record